These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30023287)

  • 1. Sex differences in body composition and bone mineral density in phenylketonuria: A cross-sectional study.
    Stroup BM; Hansen KE; Krueger D; Binkley N; Ney DM
    Mol Genet Metab Rep; 2018 Jun; 15():30-35. PubMed ID: 30023287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Medical Foods Provide a High Dietary Acid Load and Increase Urinary Excretion of Renal Net Acid, Calcium, and Magnesium Compared with Glycomacropeptide Medical Foods in Phenylketonuria.
    Stroup BM; Sawin EA; Murali SG; Binkley N; Hansen KE; Ney DM
    J Nutr Metab; 2017; 2017():1909101. PubMed ID: 28546877
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods.
    Stroup BM; Ney DM; Murali SG; Rohr F; Gleason ST; van Calcar SC; Levy HL
    J Nutr Metab; 2017; 2017():6859820. PubMed ID: 29464117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency.
    Coakley KE; Felner EI; Tangpricha V; Wilson PWF; Singh RH
    JIMD Rep; 2017; 36():67-77. PubMed ID: 28130717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex effects of dietary protein source and acid load on renal and bone status in the Pah
    Stroup BM; Murali SG; Schwahn DJ; Sawin EA; Lankey EM; Bächinger HP; Ney DM
    Physiol Rep; 2019 Oct; 7(20):e14251. PubMed ID: 31650703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of bone mineral density in adults with phenylketonuria.
    Rocha JC; Hermida Á; Jones CJ; Wu Y; Clague GE; Rose S; Whitehall KB; Ahring KK; Pessoa ALS; Harding CO; Rohr F; Inwood A; Longo N; Muntau AC; Sivri S; Maillot F
    Orphanet J Rare Dis; 2024 Sep; 19(1):338. PubMed ID: 39267130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
    de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
    Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
    Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.
    Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; Strauss BJ; Wilcox G; Fraser WD; Tang JCY; MacDonald A
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in patients with phenylketonuria.
    Zeman J; Bayer M; Stepán J
    Acta Paediatr; 1999 Dec; 88(12):1348-51. PubMed ID: 10626520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific and age-specific characteristics of body composition and its effect on bone mineral density in adults in southern China: a cross-sectional study.
    Xiao Z; Tan Z; Shang J; Cheng Y; Tang Y; Guo B; Gong J; Xu H
    BMJ Open; 2020 Apr; 10(4):e032268. PubMed ID: 32312724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying sex-specific risk factors for low bone mineral density in adolescent runners.
    Tenforde AS; Fredericson M; Sayres LC; Cutti P; Sainani KL
    Am J Sports Med; 2015 Jun; 43(6):1494-504. PubMed ID: 25748470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.